Evaxion Biotech A/S

EVAX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$10,572$14,746$17,843$5,052
Short-Term Investments$0$0$0$0
Receivables$0$864$0$1,858
Inventory$0$0$0$0
Other Curr. Assets$0$2,567$0$1,855
Total Curr. Assets$10,572$18,177$17,843$8,765
Property Plant & Equip (Net)$0$3,623$0$3,514
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$464$0$44
Tax Assets$0$0$0$0
Other NC Assets$19,165$185$7,396$162
Total NC Assets$19,165$4,272$7,396$3,720
Other Assets$0$0$0$0
Total Assets$29,737$22,449$25,239$12,485
Liabilities
Payables$0$2,496$0$2,968
Short-Term Debt$0$540$0$473
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$0$2,286$0$927
Total Curr. Liab.$0$5,322$0$4,368
LT Debt$0$10,743$0$9,628
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,138$158$14,918$141
Total NC Liab.$13,138$10,901$14,918$9,769
Other Liabilities$0$0$0$0
Cap. Leases$0$2,068$0$1,934
Total Liabilities$13,138$16,223$14,918$14,137
Equity
Pref Stock$0$0$0$0
Common Stock$13,813$11,823$11,823$10,516
Retained Earnings-$127,322-$124,948-$120,112-$118,539
AOCI$130,108-$3,076$118,610-$3,595
Other Equity$0$122,427$0$109,966
Total Equity$16,599$6,226$10,321-$1,652
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$29,737$22,449$25,239$12,485
Net Debt-$10,572-$3,463-$17,843$5,049